Tata Chemicals yesterday declared its financial results for the quarter ended 31 March, 2021. On a standalone basis, the income from operations rose by 15% to Rs 841 crore, as compared to Rs 734 crore of the corresponding quarter of last year. PAT for the period on standalone basis stood at Rs120 crore, as compared to Rs 118 crore of the corresponding quarter of last year.

On a Consolidated basis, for the quarter, the income from operations rose by 11% to Rs2,636 crore, as compared to Rs 2,378 crore of the corresponding quarter of last year. PAT for the period on consolidated basis stood at Rs29 Cr down by 85%, as compared to Rs198 crore of the corresponding quarter of last year.

On a standalone basis, for the full year, the income from operations rose by 3% to Rs 2,999 crore, as compared to Rs 2,920 crore as compared to FY2020. PAT on standalone basis stood at Rs 479 crore, down by 29%, as compared to Rs 672 crore for the corresponding last year.

On a consolidated basis, for the full year, the income from operations stood at Rs 10,200 crore, as compared to Rs 10,357 crore as compared to FY2020. PAT on Consolidated basis stood at Rs 436 crore, down by 58%, as compared to Rs 1,028 crore for the corresponding last year.

The company’s results by reporting segment showed income from operations, for the quarter, for the Basic Chemistry Products at Rs792 Cr, up by 13%, and Specialty Products at Rs49 Cr, up by 59%, as compared to the corresponding quarter of last year (CY Revenue of Rs153 Cr Up by 106% for full year).

Commenting on the results, R. Mukundan, Managing Director & CEO, Tata Chemicals Ltd., said, “During the year, we witnessed a sequential improvement in demand and this quarter saw continuation of the same trend. With the second wave of COVID-19, our priority will be the health and safety of our stakeholders and we are undertaking several initiatives to cater to the well-being of the employees and communities. During the quarter, our profits were muted due to one off in US operations caused by Polar Vortex leading to sharp rise in gas prices. There was one off in UK operations due to tax asset write off, re-financing cost. We are witnessing strengthening of Spot soda ash prices which will ease margin pressures sequentially in the coming quarters. Going forward, time bound commissioning of capacities in Mithapur and Dahej coupled with growth of Specialty products are critical steps towards transformation of the company.”

Standalone Highlights Q4FY2021

• Continued priority on the safety and health of employees and other stakeholders amidst the second wave of COVID-19. Focus on plant operations with all COVID protocols continues
• Soda ash and Bicarb demand was firm and above pre-COVID levels in the quarter
• Cement demand was strong throughout the quarter and the prices were also on higher levels
• Food and rubber grade specialty silica have received well acceptance in the domestic market
• Prebiotics reported increase in volumes driven by strong customer engagements in international market along with increasing healthy food preferences of consumers. We will continue to witness growth in FOS (Fructo Oligosaccharide), Prebiotic and Dietary Fibre 

Consolidated Highlights Q4FY2021

• Effective working capital management leading to Strong Cash flow from Operations i.e. Rs 2,037 Cr vs Rs1,780 Cr PY
• There was a Rs 45 Cr one-off impact in US operations due to spike in energy prices due to Polar Vortex
• UK operations also had one offs i.e. Tax asset write off Rs 16.5 Cr and Rs 7.5 Cr refinance cost & impact due to floods
• Expect demand of soda ash and related products in North America, UK and Kenya to continue to sequentially improve in 2021-22
• In the US, while contract prices for calendar year are lower, export spot prices are seeing positive movement
• Plant capacity utilization remains high in Q4 with stabilization in demand
• Rallis India reported Q4 Consolidated Revenues at Rs471 Crs and PAT growth of at Rs 8 Crs 

Key Highlights – YTD

• Soda Ash demand improved in Q4 of FY21. Helped recover some of the lost volumes in H1, resulting in overall offtake achievement close to previous year
• Bicarb demand remained steady except for some disruption in Q1. Volumes remained flat on yearly basis.
• Extended our distribution network for Pre-biotics in North America, Europe, and South-East Asia. Commenced serving commercial shipments in some of these markets
• Rallis India new brand architecture rollout underway. Successfully launched four new products in crop care, six in crop utrition and four in seeds segment
• With strong collections, it maintained optimum cash flow throughout the year
• Accelerated digital initiatives from product trials to employee and farmer engagements